Innovation at Bellvitge University Hospital
Bellvitge University Hospital (HUB) stands out as a benchmark in Catalonia in the treatment of multiple sclerosis, thanks to its constant search for new technologies and methods to address this complex disease.
A Pioneering Project: ImaginEM
In partnership with Novartis and icometrix, the HUB has launched the innovative ImaginEM project, which incorporates artificial intelligence to optimize the diagnosis and monitoring of multiple sclerosis through advanced analysis of magnetic resonance imaging.
icobrain Technology: A Revolutionary Tool
The icobrain tool, which has arrived in Spain for the first time, allows for a precise evaluation of brain structures and the identification of lesions in early stages, which significantly improves clinical care.
Improving Neurological Assessment
Artificial intelligence plays a crucial role in alerting physicians to subtle changes in MRIs that could precede disease progression. This not only facilitates more accurate diagnosis, but also offers quantitative biomarkers that optimize communication between professionals.
International Experience
With more than a decade of use in hospitals in Belgium and the United States and with a vast database analyzed, the effectiveness of icobrain has been proven, marking a milestone in the integration of this technology into the Spanish health system.
Impact on Patient Care
This innovative project, which will last for one year, promises to benefit a large number of patients, as the HUB serves one in ten people diagnosed with multiple sclerosis in Catalonia.
Expert Opinions
Antoni Martínez Yélamos, head of the Neurology Department, highlights that this tool will allow for a more rigorous evaluation of treatments through an objective quantification of changes in resonances. Meanwhile, Matías Pérez, from Novartis, stresses that this collaboration represents a significant step towards modernizing care for these patients.
icometrix satisfaction
The company behind icobrain, icometrix, is excited about this collaboration, highlighting that its technology facilitates an automatic and objective assessment of MRIs, thus improving the clinical management of patients with multiple sclerosis.
Final Reflections
The implementation of solutions such as icobrain in the healthcare system not only promises to transform the way multiple sclerosis is diagnosed and monitored, but could also lay the groundwork for future advances in the treatment of other neurological diseases.
